LBF20207PG50: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010094 | |LipidMaps=LMFA03010094 | ||
|SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | ||
|Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester&& (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid&& | |Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester&&(5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid&& | ||
}} | }} |
Revision as of 00:02, 20 December 2008
IDs and Links | |
---|---|
LipidBank | XPR8048 |
LipidMaps | LMFA03010094 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG50 |
15-epi-prostaglandin E2acetate, methyl ester | |
---|---|
Structural Information | |
(5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|